Board of Directors visit Celltechna's Gene Therapy Centre in Vilnius
▶

Board of Directors visit Celltechna's Gene Therapy Centre in Vilnius

NIB financed the Baltics’ first Gene Therapy Centre in Vilnius. The state-of-the-art facility paves the way for advancements in both research and manufacturing processes. Opened in September, the Centre further boosts Lithuania’s rapidly growing life sciences sector. Currently, it generates approximately 2.5% of the country’s GDP, but aims to increase this share to 5% by 2030.